Captor Therapeutics ® Investor Relations

      Investor Relations

      List of shareholders holding at least 5% of votes at the Ordinary General Meeting of the Company on 29 June 2021

      Publication date: 2021-06-30
      Number: RB ESPI 21/2021

      Current report no. 21/2021

      Date of preparation: 30 June 2021

      Subject: List of shareholders holding at least 5% of votes at the Ordinary General Meeting of the Company on 29 June 2021

      Legal basis: Article 70 point. 3 of the Act on Public Offering and Conditions Governing the Introduction of Financial Instruments to Organized Trading System and of Public Companies dated 29 July 2005

      The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the “Company”) provides the list of shareholders of the Company holding at least 5% of votes at the Ordinary General Meeting of the Company which was held on 29 June 2021:

      1. Michał Walczak who was entitled to 1,456,395 votes which constituted 38.20% votes at such General Meeting and constitutes 27.61% of the total number of votes;
      2. Paweł Holstinghausen Holsten who was entitled to 860,291 votes which constituted 22.56% votes at such General Meeting and constitutes 16.31% of the total number of votes;
      3. Sylvain Cottens who was entitled to 526,730 votes which constituted 13.82% votes at such General Meeting and constitutes 9.98% of the total number of votes;
      4. Filip Jeleń who was entitled to 269,075 votes which constituted 7.06% votes at such General Meeting and constitutes 5.10% of the total number of votes;
      5. Marek Skibiński who was entitled to 261,076 votes which constituted 6.85% votes at such General Meeting and constitutes 4.95% of the total number of votes; and
      6. Twiti Investments Limited with its registered office in Cyprus which was entitled to 204,458 votes which constituted 5.36% votes at such General Meeting and constitutes 3.88% of the total number of votes.